the honest EFSA 2011 non-substantiation and the excellent safety record (GRAS status, no serious effects to 900 mg/day) versus Dihexas unproven HGF/c-Met synaptogenesis, the fosgonimeton LIFT-AD failure and the pro-proliferative c-Met concern, and why the cheap, safe, legal tea amino acid wins comprehensively
The interaction question may be largely moot for standard oral formulations not because glutathione is inert, but because so little of it survives digestion
In 2008, Calzada obtained a TGA classification of AOD-9604 as a supplementary substance in Australia, not as a drug, but as a safe component of food supplements
Both peptides, reportedly investigated for similar physiological targets, differ in pharmacokinetic properties, particularly their half-life